Table 1.
Patient characteristics at baseline.
| Subject | Age (years) | Sex | Years since Dx | Weight (kg) | BMI (kg/m2) | BMI SDS |
| 1 | 15.8 | F | 4.4 | 95.5 | 34.7 | 2.03 |
| 2 | 18.3 | F | 4.7 | 135.3 | 45.4 | 2.41 |
| 3 | 16.2 | F | 6.3 | 92.4 | 35.4 | 2.00 |
| 4* | 11.4 | F | 5.7 | 66.0 | 32.8 | 2.32 |
| 5 | 16.1 | M | 8.0 | 121.6 | 37.7 | 2.54 |
| 6* | 15.9 | F | 8.7 | 156.5 | 65.1 | 2.96 |
| 7 | 14.7 | M | 7.3 | 75.7 | 28.3 | 1.8 |
| 8 | 17.1 | M | 8.1 | 112.0 | 34.0 | 2.14 |
| 9 | 9.2 | F | 2.8 | 56.8 | 29.6 | 2.48 |
Dx: diagnosis of craniopharyngioma; BMI: body mass index; SDS: standard deviation score. *Denotes subjects who were withdrawn from the study due to vomiting with mild elevation of hepatic enzymes (subject 4) and peripheral edema (subject 6).